Ataciguat’s Headway in Aortic Stenosis; Baby Pacemakers; AI-ECG Tool for the ED?

(MedPage Today) — The nitric oxide-independent soluble guanylate cyclase activator ataciguat continued to show promise for slowing the progression of fibrocalcific aortic valve stenosis in phase I and II studies. (Circulation)
The extent of myocardial…

Source link : https://www.medpagetoday.com/cardiology/prevention/114364

Author :

Publish date : 2025-02-25 19:08:35

Copyright for syndicated content belongs to the linked Source.